Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 3,805-3,816 of 10,592
Drug study icon
CompletedNCT00936299

Bupropion for ADHD in Adolescents With Addiction

This study exists to compare options and see whether smoking support or smoking-related treatment offers something meaningfully different. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.

In United States
Addiction, ADHDDrugA study involving a medication or substance.From 13 Years to 19 Years
Countries
United States
Sponsor
University of Colorado, Denver
Condition
Addiction, ADHD
Drug study icon
CompletedNCT01390246

Bupropion for Smoking Cessation During Pregnancy

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugOver 18 Years
Countries
United States
Sponsor
The University of Texas Medical Branch, Galveston
Condition
Addiction
Drug study icon
CompletedNCT00534001

Bupropion in Helping Adults Stop Smoking

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Roswell Park Cancer Institute
Condition
Addiction
Other study type icon
WithdrawnNCT01507675

Burden, Belonging, and Response to Pain in Veterans

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SuicidalityOtherOver 18 Years
Countries
United States
Sponsor
VA Eastern Colorado Health Care System
Condition
Suicidality
Behavioral study icon
CompletedNCT04807517

Buspirone Treatment of Anxiety in Williams Syndrome

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AnxietyBehavioralFrom 5 Years to 65 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Anxiety
Drug study icon
CompletedNCT02132832

Buspirone, Stress, and Attentional Bias to Marijuana Cues

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugFrom 18 Years to 45 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Addiction
Drug study icon
CompletedNCT03708315

BXCL501 for Agitation in Schizophrenia

This study exists to better understand the safety of a medication treatment and how manageable it feels in practice. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

In United States
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
Drug study icon
TerminatedNCT05662306

C-Cog in Early Course Schizophrenia Study

This study exists to explore whether this type of care could improve care and understanding. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.

In United States
SchizophreniaDrugOver 18 Years
Countries
United States
Sponsor
University of Miami
Condition
Schizophrenia
Behavioral study icon
CompletedNCT06061952

CAE for Poorly Adherent Individuals With Schizophrenia

This study exists to see whether questionnaires and follow-up reports is workable and worth testing more broadly. Researchers are trying to understand whether questionnaires and follow-up reports can make support easier to access outside standard clinic visits.

Remote / online
SchizophreniaBehavioralOver 18 Years
Countries
United States
Sponsor
University Hospitals Cleveland Medical Center
Condition
Schizophrenia
Behavioral study icon
CompletedNCT03408873

CAE Plus LAI in Individuals With Bipolarity at Risk for Treatment Non-adherence (BD-CAEL)

This study exists to see whether psychoeducation, a guided learning and support program, can play a useful role in care. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can work better when mental health difficulties overlap with substance use.

In United States
BipolarityBehavioralOver 18 Years
Countries
United States
Sponsor
Martha Sajatovic
Condition
Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.